Immunology

Aim to use the dose that achieves a significant reduction in the number of infections. SCIG and IVIG are equally effective. Continued use of IG should be based on objective measures of effectiveness established at the outset of treatment. These measures should be assessed no later than 6 months after initiation of treatment and at least annually thereafter by a physician with recognized expertise in immunodeficiency disorders.